Mark A. Kay MD, PhD

Scientific Advisor

Mark Kay is an acknowledged leader in the field of gene therapy and is a leading researcher in both viral and non-viral gene transfer vector systems. Dr. Kay is the Dennis Farrey Family Professor in Pediatrics, and a professor of genetics at Stanford University School of Medicine, where he heads the division of human gene therapy. He is one of the founders of the American Society of Gene and Cell Therapy, served as its president from 2005 to 2006, and was the recipient of the society’s Outstanding Investigator Award in 2013. Dr. Kay received the E. Mead Johnson Award for Research in Pediatrics in 2000. He was elected to the American Society for Clinical Investigation in 1997 and the Association for American Physicians in 2010.

Dr. Kay holds a Bachelor of Science in Physical Sciences from Michigan State University, a Ph.D. in Developmental Genetics and a M.D. from Case Western Reserve University.

© 2020 Carmine Therapeutics, Inc.

All Rights Reserved.

an

Company